Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2009

01-09-2009 | Epidemiology

Analysis of the effect of age on the prognosis of breast cancer

Authors: C. Cluze, M. Colonna, L. Remontet, F. Poncet, E. Sellier, A. Seigneurin, P. Delafosse, N. Bossard

Published in: Breast Cancer Research and Treatment | Issue 1/2009

Login to get access

Abstract

To explore the effect of age at diagnosis on relative survival from breast cancer at different cancer stages and grades, using appropriate statistical modeling of time-varying and non-linear effects of that prognostic covariate. Data on 4,791 female invasive breast cancers diagnosed between 1990 and 1997 were obtained from a French cancer registry. The effect of age on relative survival was studied using an approach based on excess rate modeling. Different models testing non-linear and non-proportional effects of age were explored for each grade and each stage. In the whole population, the effect of age was not linear and varied with the time elapsed since diagnosis. When analyzing the different sub-groups according to grade and stage, age did not have a significant effect on relative survival in grade 1 or stage 3 tumors. In grade 2 and stage 4 tumors, the excess mortality rate increased with age, in a linear way. In grade 3 tumors, age was a time-dependent factor: older women had higher excess rates than younger ones during the first year after diagnosis whereas the inverse phenomenon was observed 5 years after diagnosis. Our findings suggest that when taking into account grade and stage, the time-varying impact of young age at diagnosis is limited to grade 3 tumors, without evidence of worst prognosis at 5 years for the youngest women.
Appendix
Available only for authorised users
Literature
3.
go back to reference Levi F, Randimbison L, La Vecchia C (1992) Breast cancer survival in relation to sex and age. Oncology 49(6):413–417PubMedCrossRef Levi F, Randimbison L, La Vecchia C (1992) Breast cancer survival in relation to sex and age. Oncology 49(6):413–417PubMedCrossRef
5.
go back to reference Winchester DP, Osteen RT, Menck HR (1996) The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78(8):1838–1843. doi:10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-YPubMedCrossRef Winchester DP, Osteen RT, Menck HR (1996) The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78(8):1838–1843. doi:10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-YPubMedCrossRef
6.
go back to reference Goldhirsch A, Wood WC, Gelber RD et al (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18(7):1133–1144. doi:10.1093/annonc/mdm271 PubMedCrossRef Goldhirsch A, Wood WC, Gelber RD et al (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18(7):1133–1144. doi:10.​1093/​annonc/​mdm271 PubMedCrossRef
7.
go back to reference Goldhirsch A, Glick JH, Gelber RD et al (2001) Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 19(18):3817–3827PubMed Goldhirsch A, Glick JH, Gelber RD et al (2001) Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 19(18):3817–3827PubMed
8.
go back to reference Figueiredo JC, Ennis M, Knight JA et al (2007) Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat 105(1):69–80. doi:10.1007/s10549-006-9433-3 PubMedCrossRef Figueiredo JC, Ennis M, Knight JA et al (2007) Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat 105(1):69–80. doi:10.​1007/​s10549-006-9433-3 PubMedCrossRef
10.
15.
17.
go back to reference Rosenberg J, Chia YL, Plevritis S (2005) The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 89(1):47–54. doi:10.1007/s10549-004-1470-1 PubMedCrossRef Rosenberg J, Chia YL, Plevritis S (2005) The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 89(1):47–54. doi:10.​1007/​s10549-004-1470-1 PubMedCrossRef
19.
go back to reference Remontet L, Bossard N, Belot A et al (2007) An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 26(10):2214–2228. doi:10.1002/sim.2656 PubMedCrossRef Remontet L, Bossard N, Belot A et al (2007) An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 26(10):2214–2228. doi:10.​1002/​sim.​2656 PubMedCrossRef
21.
go back to reference Sant M, Gatta G, Micheli A et al (1991) Survival and age at diagnosis of breast cancer in a population-based cancer registry. Eur J Cancer 27(8):981–984PubMedCrossRef Sant M, Gatta G, Micheli A et al (1991) Survival and age at diagnosis of breast cancer in a population-based cancer registry. Eur J Cancer 27(8):981–984PubMedCrossRef
22.
go back to reference Sant M, Capocaccia R, Verdecchia A et al (1998) Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer 77(5):679–683. doi:10.1002/(SICI)1097-0215(19980831)77:5<679::AID-IJC3>3.0.CO;2-SPubMedCrossRef Sant M, Capocaccia R, Verdecchia A et al (1998) Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer 77(5):679–683. doi:10.1002/(SICI)1097-0215(19980831)77:5<679::AID-IJC3>3.0.CO;2-SPubMedCrossRef
24.
go back to reference Kirova YM, Stoppa-Lyonnet D, Savignoni A et al (2005) Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer 41(15):2304–2311. doi:10.1016/j.ejca.2005.02.037 PubMedCrossRef Kirova YM, Stoppa-Lyonnet D, Savignoni A et al (2005) Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer 41(15):2304–2311. doi:10.​1016/​j.​ejca.​2005.​02.​037 PubMedCrossRef
Metadata
Title
Analysis of the effect of age on the prognosis of breast cancer
Authors
C. Cluze
M. Colonna
L. Remontet
F. Poncet
E. Sellier
A. Seigneurin
P. Delafosse
N. Bossard
Publication date
01-09-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0222-z

Other articles of this Issue 1/2009

Breast Cancer Research and Treatment 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine